The strategic partnership brings together the leader in data intelligence and the leader in compliance and business development — three disciplines this industry has always bought separately — giving operators a way to grow into new therapies and business lines without building multiple internal teams to do it
FOR IMMEDIATE RELEASE
INDIANAPOLIS August 12, 2026 — MedEdge Solutions, the leader in data intelligence for specialty and infusion pharmacies, and Sphinx Strategies, LLC, the leader in compliance and business development for specialty and infusion pharmacies, today announced a strategic partnership built to power growth into new therapies and business lines for specialty and infusion pharmacies, and to strengthen business development across the industry as a whole. The partnership takes aim at the constraint that limits growth for nearly every independent operator in this market: expanding into a new therapy or business line requires proving you can both launch it correctly — accreditation, licensure, payer contracting, clinical readiness — and deliver the data that follows it, and almost nobody can staff for both.
Growth in this industry today rarely comes from opening more locations. There are only so many patients in a churn market, which means expansion may happen faster through new therapies and new lines of business. Every one of those brings its own stack. Dual accreditation. A payer or PBM contract. Appropriate licensure. A clinical protocol. Staff readiness. And once the program goes live, a data obligation the pharmacy does not control, arriving on a cadence set by manufacturers, payers, hubs, aggregators, and 340B bodies, each wanting its own format, validated before it moves.
Historically an operator had two options, and neither one was ideal. Build the capability internally, which means competing for talent that is scarce, expensive, and free to leave the moment a better offer appears. Or stitch together firms that do not talk to each other and hope the handoff holds.
That is the gap the two companies are closing. MedEdge and Sphinx have each spent years working exclusively inside specialty and infusion pharmacy, on opposite halves of the same problem. The partnership brings those halves together on one coordinated timeline, with one accountable path from launch design through delivered data.
The two firms are bringing the combined practice to market under the name Protocol to Proof.
Sphinx’s half covers clinical program design and compliance, operational workflow and staff readiness, business development, payer and PBM contracting, licensure strategy, accreditation and certification readiness, and patient access. The question Sphinx answers is whether a launch is being run correctly.
MedEdge’s half begins where that ends: locating the data inside the systems these organizations already run, validating it against manufacturer, payer, and program rules, resolving exceptions before anything moves, and automating delivery to every party that requires it. The question MedEdge answers is whether a pharmacy can demonstrate what happened, on demand, without anyone assembling it by hand.
Neither firm requires a pharmacy to change platforms. Both work inside the dispensing and clinical systems these organizations already run, which means no migration project and no new software to buy in order to use either side of the partnership.
"Growth in this market has always been rationed by talent," said Brandon Carpenter, CEO and Founder of MedEdge Solutions. "Every new therapy or line of business demands two scarce skill sets at once: the people who can get you licensed and contracted, and the people who can shoulder the data obligations that begin the moment you go live. Very few organizations can recruit and retain both simultaneously. That constraint is now gone. Sphinx executes the launch, MedEdge validates and automates the associated data intelligence, and the operator is free to scale."
"Independent pharmacies are being asked to compete like national chains while operating with a fraction of the infrastructure," said Vic Simianu, Principal and Managing Partner at Sphinx Strategies. "We can get an operator accredited, licensed, and positioned to pursue a new therapy or line of business effectively. What we could never guarantee was everything the data obligations that follow. MedEdge can, and they do it inside the systems these pharmacies already run. That is the entire premise of this partnership."
The partnership is aimed at pharmaceutical manufacturers launching specialty and infusion therapies, specialty and infusion pharmacy networks, health systems and infusion suites, and the widening set of organizations entering this space, including hubs, non-commercial dispensing entities, nursing agencies, distributors, and wholesalers. Sphinx and MedEdge will take the partnership to the industry through a co-hosted educational series, association engagement with NHIA, NASP, and IGNS, and a recurring briefing for the trade press and analysts who cover this market.
Both firms operate exclusively inside specialty and infusion pharmacy. Neither has brought this work together under one partnership before, and neither has seen anyone else do it in this market.
About MedEdge Solutions
MedEdge Solutions is a specialty and infusion pharmacy data intelligence and automation company, headquartered in Indianapolis, Indiana. MedEdge finds, validates, and fixes the data inside the complex systems that run specialty and infusion pharmacy operations and automates that data out to the people who need it, without manual intervention. MedEdge does not replace the platforms pharmacies and infusion providers already run on; it makes the data inside them work the way it should. For more information, visit www.mededgesolutions.com.
About Sphinx Strategies
Sphinx Strategies, LLC is an independent specialty pharmacy consulting group headquartered in Indianapolis, Indiana, with a mission to become the nation’s most trusted independent specialty pharmacy consulting group. Sphinx advises specialty and infusion pharmacies across clinical program design and compliance, operations and business development, payer and PBM contracting and licensure strategy, 340B, and accreditation and certification readiness. Its platforms include Spryng, a network connecting independent pharmacies to restricted drug access, industry partnerships, contracting opportunities, and data agreements; Syltos and AccreditGuard, which manage compliance, licensure, and training obligations; and Tempyl, which delivers pipeline intelligence and market insight to pharmacy operators. Sphinx Strategies was named 2024 Impact Company of the Year. For more information, visit www.sphinxstrategies.com.
